# Aviir

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/aviir

- Industry: Healthcare Specialists
- Headquarters: Irvine, US
- Website: www.aviir.com
- Total disclosed funding: $47M
- Latest round: Series B (Jun 21, 2013)
- Investors on record: 5

## About

Aviir Inc. is a US based company operates as a provider of cardiometabolic tests and services for the prevention and management of cardiovascular diseases.

## Funding rounds

- Series B, Jun 21, 2013, $10M — Aberdare Ventures, New Leaf Venture Partners, Bay City Capital, Merck Global Health Innovation Fund
- Series B, Feb 12, 2013, $10M — Aberdare Ventures, New Leaf Venture Partners, Bay City Capital, Merck Global Health Innovation Fund
- Series B, Dec 20, 2011, $10M — Aberdare Ventures, New Leaf Venture Partners, Bay City Capital, Merck Global Health Innovation Fund
- Series B, Oct 19, 2009, $1M — Aberdare Ventures, New Leaf Venture Partners, Bay City Capital
- Series B, Aug 5, 2009, $1M — Aberdare Ventures, New Leaf Venture Partners, Bay City Capital
- Series B, Mar 19, 2008, $1.5M — Aberdare Ventures, New Leaf Venture Partners, Bay City Capital
- Series B, Sep 10, 2007, $11M — Aberdare Ventures, New Leaf Venture Partners, Bay City Capital
- Seed, Mar 1, 2007, $0.1M — Ritchie Capital Management
- Seed, Oct 24, 2006, $1.5M — Ritchie Capital Management

## Investors

- Ritchie Capital Management (https://capitalatlas.ai/funds/ritchie-capital-management) — Seed
- Aberdare Ventures (https://capitalatlas.ai/funds/aberdare-ventures) — Series B
- New Leaf Venture Partners (https://capitalatlas.ai/funds/new-leaf-venture-partners) — Series B
- Bay City Capital (https://capitalatlas.ai/funds/bay-city-capital) — Series B
- Merck Global Health Innovation Fund (https://capitalatlas.ai/funds/merck-global-health-innovation-fund) — Series B